Myeloma Institute Video Library

Why should I be treated at an academic medical center?
What do I need to know about multiple myeloma?
Drug Trial for Castleman’s Gets Amazing Results
Why should I travel to Arkansas to be treated for multiple myeloma?
Andy Shapira - A Patient Testomonial
David Fajgenbaum Survivor Story
My advice to myeloma patients
UAMS -- Cancer and Myeloma Treatment -- Sean's Story
Expert Perspective: Optimizing Care Through Clinical Trials for Myeloma
Expert Perspective: Maximizing and Understanding Myeloma Treatment Approaches
Inspiring and Encouraging Words From a Myeloma Survivor
Care Partner Support: Working Together as a Couple
An Explanation of Myeloma
Choosing Treatment for YOUR Myeloma
Transplant as an Effective Treatment for Multiple Myeloma
How Oncology Social Workers Can Help
How to Take of Yourself and Prevent Infection With Myeloma
An Expert Explains Why to Consider a Myeloma Clinical Trial
Where Does Immunotherapy Fit in With Myeloma Treatment?
Myeloma Remission: Managing Life After Treatment
Should Multiple Myeloma Patients Undergo Genetic Testing?
Myeloma 2016: Panel discussion on the status of genomics
Myeloma 2016: Panel discussion on the new treatment paradigm
The mechanisms driving relapse in multiple myeloma
The clinical implications of progenitor cells in multiple myeloma
Identification of high-risk disease using molecular profiling by Mymap
The FORTE clinical trial of carfilzomib in multiple myeloma
Utilizing new understanding in multiple myeloma biology to guide treatment
Is FISH becoming obsolete in multiple myeloma?
Treatment at first relapse in multiple myeloma: how to choose a drug?
An all-molecular diagnostic approach for myeloma
The importance of the microenvironment in multiple myeloma
Novel kinase targets as emerging therapies for multiple myeloma
Are we ready for mutational directed treatment: addressing the genomic basis of myeloma
Frontline treatment for young multiple myeloma patients
Goals of Therapy for Symptomatic Myeloma
Risk Stratification for Myeloma
MRD Negativity in Multiple Myeloma
Optimal Timing for Transplantation in Myeloma
Living Well With Multiple Myeloma: Understanding Genetics and Developing Research
Why do many MM patients relapse after being treated with targeted therapy?
Will Circulating Tumor DNA Test Replace Bone Biopsy Test in Myeloma?
Does a Myeloma Patient Need to Be in Remission to Benefit From the Black Swan Initiative?
Any Updates on the Use of the New Immuno-Drugs for Maintenance in Myeloma?
Why Doesn’t Transplant Cure Multiple Myeloma?
Should I Discontinue or Continue Revlimid If I Remain MRD Negative?
ASH 2017: Are Experts Personalizing Therapy to the Genetics of a Patient’s Myeloma